Neuroloxía
Servizo
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (169)
2024
-
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
Trials, Vol. 25, Núm. 1
-
Systemic biomarker associated with poor outcome after futile reperfusion
European Journal of Clinical Investigation, Vol. 54, Núm. 6
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia, Vol. 38, Núm. 6, pp. 379-386
-
Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study
Neurologia, Vol. 38, Núm. 6, pp. 412-418
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
-
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
-
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Multiple Sclerosis Journal, Vol. 28, Núm. 7, pp. 1138-1145
2021
-
Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial
Antioxidants, Vol. 10, Núm. 8
-
Blood biomarker panels for the early prediction of stroke-associated complications
Journal of the American Heart Association, Vol. 10, Núm. 5, pp. 1-8
-
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
BMC Neurology, Vol. 21, Núm. 1
-
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat® Methodology
Frontiers in Neurology, Vol. 12
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
-
Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology
Neurologia, Vol. 36, Núm. 4, pp. 305-323
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442
2020
-
Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study
Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663
-
Blood biomarkers predictive of epilepsy after an acute stroke event
Epilepsia, Vol. 61, Núm. 10, pp. 2244-2253